Articles Tagged With:
-
Reproductive Health Workforce May Look Different in 10 Years
The reproductive health workforce has changed considerably in the past few years. It is possible it will continue to evolve over the next decade. COVID-19 placed an incredible strain on the workforce, and it is facing a second huge strain because of the U.S. Supreme Court’s decision to overturn Roe v. Wade.
-
Too Many Physicians Lack Accurate Information About Contraception
New research revealed that a significant number of physicians hold erroneous beliefs about how contraceptives work. Many believe emergency contraception causes abortions, and some doctors believe IUDs and other forms of birth control also work as abortifacients, according to a study of Wisconsin physicians’ beliefs about contraception.
-
When Lawmakers Make Medical Decisions, Patients and Providers Suffer
Recent suggests a future in which doctors in abortion-ban states will have to ask how much of a threat of death is needed before they can give patients the care needed to prevent their death or serious morbidity.
-
Legality and Chilling Effect of Abortion Care in Dobbs Era
In this Q&A about how state abortion bans are affecting women with both planned and unplanned pregnancies, Contraceptive Technology Update addresses some of the legal issues raised by state laws and bans.
-
More Research Needed on Link Between Hormonal Contraceptives and Stress
Reproductive health clinicians and their patients need more information about how hormonal contraceptives may affect people’s mood changes and depression, according to the authors of a recent paper.
-
A Simple Intervention to Reduce Surgical Site Infections?
This multicenter, cluster randomized trial in Benin, Ghana, India, Mexico, Nigeria, Rwanda, and South Africa evaluated the effect of changing sterile gloves and instruments at the time of abdominal wound closure on surgical site infection (SSI) rates among adults and children undergoing both elective and emergent surgery. The SSI rate in the intervention group among 5,789 patients was 16% compared to 18.9% in the control group of 6,768 patients (adjusted risk ratio, 0.87; 95% confidence interval, 0.79-0.95).
-
Effectiveness of an Online e-Health Program in Ameliorating Postpartum Depression
This study demonstrated that combined use of universal depression screening and MomMoodBooster2, a cognitive behavioral therapy-based e-health program, were effective tools for treating women with depression in the perinatal period.
-
Ibrexafungerp for Vulvovaginal Candidiasis
A randomized clinical trial compared one day of oral ibrexafungerp with placebo for female patients with vulvovaginal candidiasis (VVC). It found ibrexafungerp to be safe and effective, with mild diarrhea the most common adverse event. Ibrexafungerp differs mechanistically from azoles and appears to be a promising new treatment for VVC.
-
Current and Future Options for Male Contraception
Following the landmark Dobbs v. Jackson Women’s Health Organization decision that ended the constitutional right to abortion in the United States, the importance of contraception has grown. This article summarizes the existing male contraceptive options and reviews the status of future ones.
-
Patients with Chronic Pain and Opioid Misuse: What Treatment Works?
Among primary care patients diagnosed with comorbid chronic pain and opioid misuse, researchers found a specially designed, mindfulness-based group therapy showed superiority to generic supportive group therapy in reducing opioid use and controlling symptoms of chronic pain.